During the past decade, Clinique BOUCHARD conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinique BOUCHARD" #1 sponsor was "Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète" with 1 trials, followed by "Elsan" with 1 trials sponsored, "Medtronic Bakken Research Center" with 1 trials sponsored, "PEAS (Pole d'Exploration des Apnees du Sommeil)" with 1 trials sponsored and "University Hospital, Brest" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinique BOUCHARD" #1 collaborator was "Central Hospital, Nancy, France" with 1 trials as a collaborator, "Institut National de la Santé Et de la Recherche Médicale, France" with 1 trials as a collaborator, "Medtronic" with 1 trials as a collaborator and "Sanofi" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Clinique BOUCHARD" are "Abdominal Aortic Aneurysm" (1 trials), "Brady-Tachy Syndrome" (1 trials), "Bradyarrhythmia" (1 trials), "Chronic Renal Failure" (1 trials) and "Diabetes" (1 trials). Many other conditions were trialed in "Clinique BOUCHARD" in a lesser frequency.

Most popular intervention types in "Clinique BOUCHARD" are "Device" (3 trials), "Drug" (2 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "DIABEO software" (1 trials), "No oral anticoagulation" (1 trials), "Oral anticoagulation with vitamin K antagonists" (1 trials), "Pacemaker Vitatron Selection 9000" (1 trials) and "Pacemaker Vitatron T70" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinique BOUCHARD" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Clinique BOUCHARD". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Clinique BOUCHARD, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Clinique BOUCHARD, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".